A Guide to the Changing Diabetes Landscape: Translating the Latest Evidence into Practice

CAN-eng

$0

gratuit

Mainpro+

1 heure

Endocrinology

1 Credits

This course is expired! Browse All Courses
APPRENDRE ENCORE PLUS

Description du cours

The diabetes landscape is rapidly changing. Since the 2018 Diabetes Canada guidelines were published, new evidence has emerged, prompting an update to the chapter on pharmacologic management of adults with type 2 diabetes (T2D). The two pillars of diabetes management include achieving glycemic targets and providing cardiovascular and renal protection.

This program is designed to discuss the updated recommendations from Diabetes Canada regarding the pharmacologic management of adults with T2D. The goal is for all participants to be able to incorporate guideline recommendations into their practice to ensure effective T2D management.

This program is developed in collaboration with M3 (EU) Ltd.

Supported by an education grant from Novo Nordisk A/S.

Détails du cours

Date d'expiration : 2022-01-26

Métiers: Médecin

Faculté

Ronald Goldenberg, MD, FRCPC, FACE

Jeffrey Habert, MD, CCFP, FCFP

Jane Ballantine, MD

Daniel Ngui, MD, CCFP, FCFP

Accréditation

This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ credit.

Cert+ Program ID#: 193592

Objectif(s) d'apprentissage

After viewing the 4 expert brief videos in this program, participants will be better able to:

  • Achieve glycemic targets in a timely fashion for patients with type 2 diabetes
  • Apply Diabetes Canada recommendations for prescribing antihyperglycemic agents that provide cardiovascular and renal protection
  • Counsel patients on common adverse events with GLP-1 RAs and SGLT2 inhibitors
  • Identify patients and clinical situations in which it would be appropriate to prescribe combination therapy of GLP-1 RAs and SGLT2 inhibitors in type 2 diabetes
This course is expired! Browse All Courses